These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 829629)

  • 1. A broader conceptualization of premorbid risk in psychoses can motivate primordial prevention.
    Oh H; Karcher NR; Schiffman J; Anglin DM; Koyanagi A; Munson MR; DeVylder JE
    Schizophr Res; 2023 Dec; 262():53-54. PubMed ID: 37925750
    [No Abstract]   [Full Text] [Related]  

  • 2. The prophylactic lithium treatment in affective disorders and the possibilities of the outcome prediction.
    Hanus H; Zapletălek M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1984; 27(1):5-75. PubMed ID: 6599636
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative characteristics of the preventive properties of short-acting and delayed-action lithium carbonate in endogenous affective psychoses].
    Panteleeva GP; Mikhaĭlova NM; Beliaev BS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):406-12. PubMed ID: 6789585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrence prophylaxis of affective diseases with lithium and their results].
    Felber W
    Psychiatr Clin (Basel); 1981; 14(3):161-6. PubMed ID: 7036230
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lithium in the prevention of manic-depressive and schizo-affective psychoses].
    Mozzicato M; Cottini R; Zampato G; Villa D; Milani T; D'Orazio G
    Minerva Med; 1978 Oct; 69(50):3457-72. PubMed ID: 733037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unsolved problems in the indications for lithium prophylaxis in affective and schizoaffective disorders].
    Angst J
    Bibl Psychiatr; 1981; (161):32-44. PubMed ID: 7271758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The prophylactic effect of lithium salt in affective psychoses with special references to patients with therapeutic failures].
    Krzyzowski J; Skaryszewska J; Marcjan K
    Psychiatr Neurol Med Psychol Beih; 1975; 20-21():235-8. PubMed ID: 829629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Lithium prophylaxis in schizoaffective psychoses].
    Lenz G; Küfferle B; Wolf R
    Bibl Psychiatr; 1981; (161):45-57. PubMed ID: 7023468
    [No Abstract]   [Full Text] [Related]  

  • 9. Mood disorders: pharmacologic prevention of recurrences. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1984; 5(4):8 p.. PubMed ID: 6398407
    [No Abstract]   [Full Text] [Related]  

  • 10. Who responds to prophylactic lithium therapy?
    Abou-Saleh MT
    Br J Psychiatry Suppl; 1993 Sep; (21):20-6. PubMed ID: 8217063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in psychiatric therapy using lithium].
    Koufen H
    Med Klin; 1978 Apr; 73(16):563-9. PubMed ID: 347236
    [No Abstract]   [Full Text] [Related]  

  • 12. Prophylactic and therapeutic profile of lithium.
    Peselow E; Lautin A; Gershon S
    Bibl Psychiatr; 1981; (161):1-31. PubMed ID: 7023466
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.